In total synchronization, the entire room turned to stare at Elara.
The rest of the guests did the same.
Even Gabriel, along with Frederick and Marjorie who were seated just a few spots down from her, locked their eyes on her.
Elara was utterly bewildered.
She blinked furiously, convinced for a fleeting second that she had imagined the whole thing.
With a thousand pairs of eyes boring into her, she stared dead ahead at Melanie.
"I don't know what you're talking about. You're not making any sense."
The moment the denial left Elara's lips, Melanie raised her phone.
"...Next Monday is the joint launch for the Royce Group and Stellaris's new diabetes drug, right? I just need you to stand up in front of all their partners and accuse Stellaris of stealing the core technology from the Carter Group's upcoming GlycaGuard L1."
The audio playing from the phone was undeniably, distinctively Elara's voice.
The color completely drained from Elara's face.
"...It's precisely because the Royce Group co-developed this drug that your words will carry weight. That's the only way Stellaris's clients will buy the story."
Hearing the exact conversation from the corporate helipad playing out loud, the crushing reality hit Elara like a freight train.
She had been played!
From the very beginning, Melanie never bought her story.
Not only did she see right through her, but she had flipped the script and recorded every word.
Panic-stricken, Elara leaped from her seat and lunged toward the stage, desperate to snatch the phone from Melanie's hand.
But the person who blocked her path wasn't Melanie.
"What exactly do you think you're doing to Ms. Royce?"
Confronted by Marjorie, Elara went rigid, sheer terror flashing in her eyes.
"Mrs. Whitmore, I... I..."
As she tried to speak, she found her tongue tied in knots. She couldn't form a single coherent excuse.
Elara's phone started ringing.
She didn't even have to check the screen to know it was her father.
A cold sweat broke out on her forehead. She stood there paralyzed, her fingers violently trembling.
At that moment, Melanie slipped her phone into her pocket and picked the mic back up.
"In reality, the new medication co-developed by Stellaris PharmaTech and the Royce Group utilizes a continuous flow enzyme catalysis process, while the Carter Group's GlycaGuard L1 relies on an immobilized enzyme loop. They share similarities, but the mechanisms are entirely distinct. This isn't theft. In fact, if used in tandem, the two drugs could offer vastly superior glucose management with drastically reduced side effects."
Listening to the expert breakdown, Marjorie couldn't hide the genuine admiration on her face.
Melanie had not only nuked Elara's conspiracy in front of the world but successfully pivoted to pitch Stellaris's drug and opened the door for a lucrative future partnership with the Carter Group.
The room exploded into a frenzy of activity as reporters rushed to file their final stories and investors frantically placed pre-orders.
With her work thoroughly accomplished, Melanie decided it was time to make her exit.
Just as she stepped outside the grand doors of Sovereign Hall, Elara charged out after her, screaming at her back.
"Stop right there!"

Comments
The readers' comments on the novel: She Left She Thrived She’s Worth Billions
Please update more chapters...